Covid-19 pandemic: WHO says boosters needed, reversing previous call

It said vaccination, including the use of boosters, was especially important for people at risk of severe disease.

vaccination
AP | PTI Geneva
2 min read Last Updated : Mar 09 2022 | 1:01 AM IST

An expert group convened by the World Health Organisation said Tuesday it strongly supports urgent and broad access to booster doses of COVID-19 vaccine amid the global spread of omicron, capping a reversal of the U.N. agency's repeated insistence last year that boosters weren't necessary for healthy people and contributed to vaccine inequity.

In a statement, WHO said its expert group concluded that immunization with authorized COVID-19 vaccines provide high levels of protection against severe disease and death amid the continuing spread of the hugely contagious omicron variant. WHO eased back on its earlier position in January by saying boosters were recommended once countries had adequate supplies and after protecting their most vulnerable.

It said vaccination, including the use of boosters, was especially important for people at risk of severe disease.

Last year, WHO's director-general Tedros Adhanom Ghebreyesus called for a moratorium on booster doses while dozens of countries embarked on administering the doses, saying rich countries should immediately donate those vaccines to poor countries instead. WHO scientists said at the time they would continue to evaluate incoming data.

The updated recommendations came from an 18-member advisory group that focuses on the impact of "variants of concern" the most worrying variants, like omicron and assesses the vaccines' effectiveness against them.

Numerous scientific studies have proven that booster doses of authorized vaccines help restore waning immunity and protect against serious COVID-19. Booster programs in rich countries including Britain, Canada and the U.S. have been credited with preventing the surge in omicron infections from spilling over into hospitals and cemeteries.

WHO said it is continuing to monitor the global spread of omicron, including a stealth version known as BA.2, which has been documented to have re-infected some people after an initial case of omicron. There's mixed research on whether it causes more severe disease, but vaccines appear just as effective against it.

WHO noted that the current authorized COVID-19 vaccines are all based on the strain that was first detected in Wuhan, China more than three years ago.

Since then, there has been continuous and substantial virus evolution and it is likely that this evolution will continue, resulting in the emergence of new variants, the agency said. It added that coronavirus vaccines would likely need to be updated.

(Only the headline and picture of this report may have been reworked by the Business Standard staff; the rest of the content is auto-generated from a syndicated feed.)

*Subscribe to Business Standard digital and get complimentary access to The New York Times

Smart Quarterly

₹900

3 Months

₹300/Month

SAVE 25%

Smart Essential

₹2,700

1 Year

₹225/Month

SAVE 46%
*Complimentary New York Times access for the 2nd year will be given after 12 months

Super Saver

₹3,900

2 Years

₹162/Month

Subscribe

Renews automatically, cancel anytime

Here’s what’s included in our digital subscription plans

Exclusive premium stories online

  • Over 30 premium stories daily, handpicked by our editors

Complimentary Access to The New York Times

  • News, Games, Cooking, Audio, Wirecutter & The Athletic

Business Standard Epaper

  • Digital replica of our daily newspaper — with options to read, save, and share

Curated Newsletters

  • Insights on markets, finance, politics, tech, and more delivered to your inbox

Market Analysis & Investment Insights

  • In-depth market analysis & insights with access to The Smart Investor

Archives

  • Repository of articles and publications dating back to 1997

Ad-free Reading

  • Uninterrupted reading experience with no advertisements

Seamless Access Across All Devices

  • Access Business Standard across devices — mobile, tablet, or PC, via web or app

More From This Section

Topics :World Health OrganizationCoronavirus TestsCoronavirus Vaccine

First Published: Mar 09 2022 | 1:01 AM IST

Next Story